Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data-Reference-Cited by-同舟云学术

Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data

Published:2020-05-05 Issue:11 Volume:51 Page:1149-1159
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Loomba Rohit¹²^ORCID,Wong Robert³^ORCID,Fraysse Jeremy⁴,Shreay Sanatan⁴,Li Suying⁵,Harrison Stephen⁶,Gordon Stuart C.⁷

Affiliation:

1. Department of Medicine; NAFLD Research Center; La Jolla CA USA

2. Division of Gastroenterology; Department of Medicine; University of California, San Diego; La Jolla CA USA

3. Division of Gastroenterology and Hepatology; Alameda Health System, Highland Hospital; Oakland CA USA

4. Health Economics Outcomes Research; Gilead Sciences; Foster City CA USA

5. Chronic Disease Research Group; Minneapolis MN USA

6. Pinnacle Clinical Research; San Antonio TX USA

7. Department of Gastroenterology and Hepatology; Henry Ford Hospital; Wayne State University School of Medicine; Detroit MI USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15679/fullpdf

Reference28 articles.

1. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030;Estes;J Hepatol,2018

2. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease;Perumpail;World J Gastroenterol,2017

3. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

4. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

5. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies;Singh;Clin Gastroenterol Hepatol,2015

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

2. Budget impact of resmetirom for the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis);Journal of Medical Economics;2024-08-22

3. Clinical performance of ultrasonic backscatter parametric and nonparametric statistics in detecting early hepatic steatosis;Ultrasonics;2024-08

4. Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care;Journal of General Internal Medicine;2024-07-26

5. Association between serum selenium and non-alcoholic fatty liver disease: Results from NHANES: An observational study;Medicine;2024-07-12